Morgan Stanley’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $144K | Sell |
|
|||||
|
2023
Q1 | $230K | Buy |
|
|||||
|
2022
Q4 | $10.6K | Buy |
|
|||||
|
2022
Q3 | $15K | Sell |
|
|||||
|
2022
Q2 | $35K | Sell |
|
|||||
|
2022
Q1 | $82K | Sell |
|
|||||
|
2021
Q4 | $1.09M | Sell |
|
|||||
|
2021
Q3 | $2.86M | Sell |
|
|||||
|
2021
Q2 | $5.87M | Buy |
|
|||||
|
2021
Q1 | $45K | Sell |
|
|||||
|
2020
Q4 | $155K | Buy |
|